News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Prevención versus Terapia. El gran avance del siglo actual
Prevention versus Therapy. The breakthrough of the current century
Healthcare
Massive data collection accelerated by the digitisation of healthcare, as well as artificial…
Partners - GENESIS Biomed
Científicos analizando muestras en un laboratorio
Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients
Healthcare · Access to innovation · Innovative drugs
Patients treated with VCN-01 (zabilugene almadenorepvec) plus gemcitabine/nab-paclitaxel standard-…
Tax Lease sin sorpresas
ORYZON awarded 13.26 million € through the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
Healthcare · Rare diseases · Innovative drugs
Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and…
Partners - Oryzon Genomics
Oficinas de la compañía biotech Natac
Natac closes 2024 with record sales of nearly 36 million euros
Corporate
The company increased its normalized EBITDA by 47%, reaching €13.82 million.
Partners - Natac Group
CEOs de las empresas Nuage Therapeutics, Ona Therapeutics y SpliceBio
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innovation in Barcelona
Healthcare · Rare diseases · Personalized medicine · Advanced therapies
Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque…
Partners - Parc Científic de Barcelona
Thumbnail
John Nicols joins ZYMVOL’s board of directors
Corporate
Partners - Zymvol Biomodeling
Estudios Gate2Brain
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
Healthcare · Innovative drugs
Together, these studies reinforce the concept that advanced peptide-based brain shuttle…
Partners - Gate2Brain
Científica observando a través de un microscopio
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
Healthcare · Access to innovation · Financing
Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners
Partners - Asabys Partners
La sede de Oryzon
ORYZON capta 30 millones de euros en una ampliación de capital internacional
Financing
Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP
Partners - Oryzon Genomics